SEC Info - CervoMed Inc. - ‘8-K’ for 3/28/24

SEC Info℠

Home

Help

Please Sign In

CervoMed Inc. – ‘8-K’ for 3/28/24

On: Thursday, 3/28/24, at 8:36am ET · For: 3/28/24 · Accession #: 1437749-24-9697 · File #: 1-37942

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  CervoMed Inc.                     8-K:1,3,7,9 3/28/24   15:1M                                     RDG Filings/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     45K 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     89K 
 3: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    229K 
 4: EX-10.1     Material Contract                                   HTML    347K 
 5: EX-99.1     Miscellaneous Exhibit                               HTML     16K 
10: R1          Document And Entity Information                     HTML     46K 
12: XML         IDEA XML File -- Filing Summary                      XML     12K 
15: XML         XBRL Instance -- crvo20240326_8k_htm                 XML     14K 
11: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 7: EX-101.DEF  XBRL Definitions -- crvo-20240328_def                XML     37K 
 8: EX-101.LAB  XBRL Labels -- crvo-20240328_lab                     XML     48K 
 9: EX-101.PRE  XBRL Presentations -- crvo-20240328_pre              XML     37K 
 6: EX-101.SCH  XBRL Schema -- crvo-20240328                         XSD     15K 
13: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    20K 
14: ZIP         XBRL Zipped Folder -- 0001437749-24-009697-xbrl      Zip    167K

Filing Submission 0001437749-24-009697 – SGML Text

Original SGML Text submitted by:	RDG Filings/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 1M ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20240328-083646	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20240328-083642	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20240328-083606	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001437749-24-009697
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		18
<PERIOD>			20240328
<ITEMS>				1.01
<ITEMS>				3.02
<ITEMS>				7.01
<ITEMS>				9.01
<FILING-DATE>			20240328
<DATE-OF-FILING-DATE-CHANGE>	20240328

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		CervoMed Inc.
<CIK>				0001053691
<ASSIGNED-SIC>			2834
<ORGANIZATION-NAME>		03 Life Sciences
<IRS-NUMBER>			300645032  ⇒ 30-0645032
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-37942
<FILM-NUMBER>			24793718
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			20 PARK PLAZA
<STREET2>			SUITE 424
<CITY>				BOSTON
<STATE>				MA
<ZIP>				02116
<PHONE>				(617) 744-4400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			20 PARK PLAZA
<STREET2>			SUITE 424
<CITY>				BOSTON
<STATE>				MA
<ZIP>				02116
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Diffusion Pharmaceuticals Inc.
<DATE-CHANGED>			20160115
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		RestorGenex Corp
<DATE-CHANGED>			20140307
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Stratus Media Group, Inc
<DATE-CHANGED>			20080722
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	crvo20240326_8k.htm
<DESCRIPTION>	FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:crvo="http://www.crvo.com/20240328">
       Show <XBRL>: 609 lines (widest: 1,536 characters) - 51K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.1
<SEQUENCE>	2
<FILENAME>	ex_645158.htm
<DESCRIPTION>	EXHIBIT 4.1
<TEXT>
<html>
       Show <HTML>: 712 lines (widest: 6,234 characters) - 90K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.2
<SEQUENCE>	3
<FILENAME>	ex_646585.htm
<DESCRIPTION>	EXHIBIT 4.2
<TEXT>
<html>
       Show <HTML>: 1,685 lines (widest: 10,303 characters) - 234K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.1
<SEQUENCE>	4
<FILENAME>	ex_646646.htm
<DESCRIPTION>	EXHIBIT 10.1
<TEXT>
<html>
       Show <HTML>: 3,030 lines (widest: 5,593 characters) - 370K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-99.1
<SEQUENCE>	5
<FILENAME>	ex_646647.htm
<DESCRIPTION>	EXHIBIT 99.1
<TEXT>
<html>
       Show <HTML>: 113 lines (widest: 2,748 characters) - 13K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.SCH
<SEQUENCE>	6
<FILENAME>	crvo-20240328.xsd
<DESCRIPTION>	XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 31 lines (widest: 719 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.DEF
<SEQUENCE>	7
<FILENAME>	crvo-20240328_def.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 70 lines (widest: 311 characters) - 12K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.LAB
<SEQUENCE>	8
<FILENAME>	crvo-20240328_lab.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 119 lines (widest: 311 characters) - 15K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.PRE
<SEQUENCE>	9
<FILENAME>	crvo-20240328_pre.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 63 lines (widest: 311 characters) - 12K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	10  ⇐ Not a Document/Exhibit
<FILENAME>	logomed.jpg
<TEXT>
       Show <TEXT>: 126 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	12  ⇒ 11  ⇐ Document/Exhibit 10
<FILENAME>	R1.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 804 lines (widest: 387 characters) - 38K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EXCEL
<SEQUENCE>	13  ⇒ 12  ⇐ Document/Exhibit 11
<FILENAME>	Financial_Report.xlsx
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 130 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	14  ⇒ 13  ⇐ Not a Document/Exhibit
<FILENAME>	Show.js
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 5 lines (widest: 296 characters) - 973 bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	15  ⇒ 14  ⇐ Not a Document/Exhibit
<FILENAME>	report.css
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 182 lines (widest: 57 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	17  ⇒ 15  ⇐ Document/Exhibit 12
<FILENAME>	FilingSummary.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
       Show <XML>: 49 lines (widest: 98 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		JSON
<SEQUENCE>	19  ⇒ 16  ⇐ Document/Exhibit 13
<FILENAME>	MetaLinks.json
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 635 lines (widest: 416 characters) - 19K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		ZIP
<SEQUENCE>	20  ⇒ 17  ⇐ Document/Exhibit 14
<FILENAME>	0001437749-24-009697-xbrl.zip
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 2,765 lines (Unix-to-Unix encoding) - 168K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	22  ⇒ 18  ⇐ Document/Exhibit 15
<FILENAME>	crvo20240326_8k_htm.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
       Show <XML>: 41 lines (widest: 124 characters) - 3K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001437749-24-009697 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

CervoMed Inc. – ‘8-K’ for 3/28/24

On: Thursday, 3/28/24, at 8:36am ET · For: 3/28/24 · Accession #: 1437749-24-9697 · File #: 1-37942

Current Report — Form 8-KFiling Table of Contents

Current Report — Form 8-K

Filing Table of Contents